Cargando…

Mutant APC promotes tumor immune evasion via PD-L1 in colorectal cancer

PD-L1 expression is elevated in various human cancers, including colorectal cancer. High levels of PD-L1 expressed on tumor epithelial cells are one of the potential mechanisms by which tumor cells become resistant to immune attack. However, PD-L1 regulation in tumor cells is not fully understood. H...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cen, Bo, Wei, Jie, Wang, Dingzhi, Xiong, Ying, Shay, Jerry W., DuBois, Raymond N.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8526383/ https://www.ncbi.nlm.nih.gov/pubmed/34385594 http://dx.doi.org/10.1038/s41388-021-01972-6

Ejemplares similares

Peroxisome Proliferator-Activated Receptors and Progression of Colorectal Cancer
por: Wang, Dingzhi, et al.
Publicado: (2008)

The Crosstalk of PTGS2 and EGF Signaling Pathways in Colorectal Cancer
por: Wang, Dingzhi, et al.
Publicado: (2011)

Myeloid-derived suppressor cells link inflammation to cancer
por: Wang, Dingzhi, et al.
Publicado: (2014)

Regulation of PD-L1: Emerging Routes for Targeting Tumor Immune Evasion
por: Wang, Yiting, et al.
Publicado: (2018)

Krüppel-Like Factor 12 Promotes Colorectal Cancer Growth through Early Growth Response Protein 1
por: Kim, Sun-Hee, et al.
Publicado: (2016)

Editorial: Targeting the PD-1/PD-L1 Cancer Immune Evasion Axis: Challenges and Emerging Strategies
por: Wang, Yiting, et al.
Publicado: (2020)

RelB upregulates PD-L1 and exacerbates prostate cancer immune evasion
por: Zhang, Yanyan, et al.
Publicado: (2022)

Hantavirus-Driven PD-L1/PD-L2 Upregulation: An Imperfect Viral Immune Evasion Mechanism
por: Raftery, Martin J., et al.
Publicado: (2018)

The cholesterol uptake regulator PCSK9 promotes and is a therapeutic target in APC/KRAS-mutant colorectal cancer
por: Wong, Chi Chun, et al.
Publicado: (2022)

Immune evasion mediated by PD-L1 on glioblastoma-derived extracellular vesicles
por: Ricklefs, Franz L., et al.
Publicado: (2018)

Tumor-Intrinsic PD-L1 Signaling in Cancer Initiation, Development and Treatment: Beyond Immune Evasion
por: Dong, Peixin, et al.
Publicado: (2018)

Editorial: Targeting the PD-1/PD-L1 cancer immune evasion axis: Challenges and emerging strategies, Volume II
por: He, Xiujing, et al.
Publicado: (2022)

Prostaglandin E(2) promotes intestinal tumor growth via DNA methylation
por: Xia, Dianren, et al.
Publicado: (2012)

APC Mutation Marks an Aggressive Subtype of BRAF Mutant Colorectal Cancers
por: Fennell, Lochlan J., et al.
Publicado: (2020)

β-Catenin induces transcriptional expression of PD-L1 to promote glioblastoma immune evasion
por: Du, Linyong, et al.
Publicado: (2020)

CXCL1 induced by prostaglandin E(2) promotes angiogenesis in colorectal cancer
por: Wang, Dingzhi, et al.
Publicado: (2006)

PD-L2 glycosylation promotes immune evasion and predicts anti-EGFR efficacy
por: Xu, Yiqi, et al.
Publicado: (2021)

Cancer immune evasion through KRAS and PD-L1 and potential therapeutic interventions
por: Watterson, Alex, et al.
Publicado: (2023)

Upregulation of PD‐L1 by SARS‐CoV‐2 promotes immune evasion
por: Huang, Hsiang‐Chi, et al.
Publicado: (2023)

LncTUG1 promotes hepatocellular carcinoma immune evasion via upregulating PD-L1 expression
por: Wu, Rongshou, et al.
Publicado: (2023)

Microparticles from tumors exposed to radiation promote immune evasion in part by PD-L1
por: Timaner, Michael, et al.
Publicado: (2019)

RIG-I promotes immune evasion of colon cancer by modulating PD-L1 ubiquitination
por: Zhang, Yangyang, et al.
Publicado: (2023)

Colorectal Cancer‐Derived Small Extracellular Vesicles Promote Tumor Immune Evasion by Upregulating PD‐L1 Expression in Tumor‐Associated Macrophages
por: Yin, Yuan, et al.
Publicado: (2022)

Current Understanding of the Mechanisms Underlying Immune Evasion From PD-1/PD-L1 Immune Checkpoint Blockade in Head and Neck Cancer
por: Kok, Victor C.
Publicado: (2020)

Therapeutic targeting truncated adenomatous polyposis coli (APC) proteins for the selective killing of colorectal cancer cells
por: Zhang, Lu, et al.
Publicado: (2014)

Mutant KRAS Drives Immune Evasion by Sensitizing Cytotoxic T‐Cells to Activation‐Induced Cell Death in Colorectal Cancer
por: Liu, Huashan, et al.
Publicado: (2023)

STT3-dependent PD-L1 accumulation on cancer stem cells promotes immune evasion
por: Hsu, Jung-Mao, et al.
Publicado: (2018)

DENR controls JAK2 translation to induce PD-L1 expression for tumor immune evasion
por: Chen, Baiwen, et al.
Publicado: (2022)

TOPK mediates immune evasion of renal cell carcinoma via upregulating the expression of PD-L1
por: Li, Jinxin, et al.
Publicado: (2023)

O-GlcNAcylation promotes tumor immune evasion by inhibiting PD-L1 lysosomal degradation
por: Zhu, Qiang, et al.
Publicado: (2023)

Vascular Immune Evasion of Mesenchymal Glioblastoma Is Mediated by Interaction and Regulation of VE-Cadherin on PD-L1
por: Luo, Jing, et al.
Publicado: (2023)

m(6)A methyltransferase METTL16 mediates immune evasion of colorectal cancer cells via epigenetically regulating PD-L1 expression
por: Wang, Ailei, et al.
Publicado: (2023)

Understanding Immune Evasion and Therapeutic Targeting Associated with PD-1/PD-L1 Pathway in Diffuse Large B-cell Lymphoma
por: Song, Moo-Kon, et al.
Publicado: (2019)

ANXA1-derived peptide for targeting PD-L1 degradation inhibits tumor immune evasion in multiple cancers
por: Yu, Zheng-Zheng, et al.
Publicado: (2023)

Complex pattern of immune evasion in MSI colorectal cancer
por: Ozcan, Mine, et al.
Publicado: (2018)

αvβ3-integrin regulates PD-L1 expression and is involved in cancer immune evasion
por: Vannini, Andrea, et al.
Publicado: (2019)

Sphingosine kinase 1 promotes tumor immune evasion by regulating the MTA3-PD-L1 axis
por: Lau, Poyee, et al.
Publicado: (2022)

PD-L1 translocation to the plasma membrane enables tumor immune evasion through MIB2 ubiquitination
por: Yu, Xinfang, et al.
Publicado: (2023)

Dysregulation of PD-L1 by UFMylation imparts tumor immune evasion and identified as a potential therapeutic target
por: Zhou, Junzhi, et al.
Publicado: (2023)

Glycolytic enzyme HK2 promotes PD-L1 expression and breast cancer cell immune evasion
por: Lin, Jichun, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t8sl8eoq9ng9dlv1d4cbd0klra